Adult Nodular Sclerosis Hodgkin Lymphoma Completed Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00337194SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin LymphomaTreatment